Biology/Computational Biology - Summer Research Program
Novavax, Inc. | |
401(k)
| |
United States, Maryland | |
Apr 07, 2026 | |
|
Novavax is global biotechnology company, committed to developing life-saving innovations that reach billions around the world. Our corporate growth strategy focuses on maximizing the impact of our cutting-edge technology by forging strategic partnerships for our R&D assets and our Matrix-M adjuvant to drive vaccine innovation that protects the health of people. By leveraging our science, our technology and our people, we will innovate and collaborate to tackle the world's most significant health challenges. Job Description We are seeking multiple highly motivated temporary employees to support cutting-edge research at the intersection of computational biology, artificial intelligence, and vaccine discovery. These positions offer a unique opportunity to be mentored by Novavax scientists while contributing to the computational design and experimental assessment of novel protein antigens by leveraging the latest advances in large language models (LLMs), GPT-based systems, and AI-driven protein engineering. The contractors will work closely with a multidisciplinary team of computational scientists and experimental biologists to accelerate next-generation vaccine antigen discovery. Key Responsibilities
Required Qualifications
Preferred Qualifications
Position Details
Our Mission By leveraging our science, our technology and our people, we will innovate and collaborate to tackle the world's most significant health challenges. Our Vision We envision a world where our technology is amplified to touch the lives of billions, sparking transformation in global health. Our Values Integrity, Collaboration, Innovation, Agility and Accountability sit at the heart of our culture. They express the mindset and behaviors that guide how we show up, how we work together and how we create impact - for patients, partners and each other. Our Footprint Novavax is proudly headquartered in the USA with main offices in Gaithersburg, Maryland. We conduct R&D and manufacturing for our Matrix-M adjuvant in Uppsala, Sweden. | |
401(k)
Apr 07, 2026